240 related articles for article (PubMed ID: 11920909)
1. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
Summers AM; Huang T; Wyatt PR
Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
[No Abstract] [Full Text] [Related]
2. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Hogge WA; Fraer L; Melegari T
Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
[TBL] [Abstract][Full Text] [Related]
4. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
5. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
[No Abstract] [Full Text] [Related]
6. Human chorionic gonadotrophin and trisomy 18.
Barkai G; Chaki R; Sochat M; Goldman B
Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814
[TBL] [Abstract][Full Text] [Related]
7. [Comment on the contribution by Benz et al.: Serum screening for Down syndrome in women under 35 years of age with an age independent index].
Reynolds T; Pistorius K; Spencer K; John R
Z Geburtshilfe Neonatol; 1995; 199(3):128-9. PubMed ID: 7553259
[No Abstract] [Full Text] [Related]
8. Maternal serum screening of Palestinian women in the West Bank.
Husseini A; Akkawi M
East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum screening.
Carroll JC
Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
[TBL] [Abstract][Full Text] [Related]
10. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE
Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
[TBL] [Abstract][Full Text] [Related]
13. [Maternal serum screening for detection of fetal chromosome abnormalities].
Holzgreve W; Miny P; Schloo R; Tercanli S
Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824
[No Abstract] [Full Text] [Related]
14. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
15. [Triple screening for trisomy 21: prospective results of 7039 assessments].
Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
[No Abstract] [Full Text] [Related]
16. Maternal serum screening and trisomy 16 confined to the placenta.
Groli C; Cerri V; Tarantini M; Bellotti D; Jacobello C; Gianello R; Zanini R; Lancetti S; Zaglio S
Prenat Diagn; 1996 Aug; 16(8):685-9. PubMed ID: 8878276
[TBL] [Abstract][Full Text] [Related]
17. Prenatal biochemical diagnostics of inborn developmental defects.
Malbohan I; Fialová L; Mikulíková L; Hájek Z
Sb Lek; 1994; 95(4):277-83. PubMed ID: 8867698
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
[TBL] [Abstract][Full Text] [Related]
19. Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
Moroz C; Maymon R; Jauniaux E; Traub L; Cuckle H
Prenat Diagn; 2000 May; 20(5):395-9. PubMed ID: 10820407
[TBL] [Abstract][Full Text] [Related]
20. Triple marker screening in native Japanese women.
Onda T; Kitagawa M; Takeda O; Sago H; Kubonoya K; Iinuma K; Bradley LA; Canick JA; Krasikov NE; Ponting NR; Grier RE
Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]